OUD

Monthly buprenorphine injections effective for opioid use disorders

A newly published study suggests the long-acting buprenorphine formulation BUP-XR is more effective than placebo in helping patients struggling with addiction to opioids. BUP-XR is a monthly extended-release injection. Daily dose buprenorphine was approved by the Food and Drug Administration (FDA) in 2002 and has proven to be effective in…

Cascade of Care model recommended for opioid crisi

A team of NIDA-funded scientists has offered a critical look at how to build an improved framework of care for the identification and treatment of people with opioid use disorder (OUD). Building upon the successful Cascade of Care model developed in 2017 to manage patients with HIV and AIDS, the…

New opioid treatment resources for emergency department clinicians

The National Institute on Drug Abuse (NIDA) today announced the availability of informational resources for clinicians interested in initiating buprenorphine treatment in emergency department settings. Buprenorphine is one of several medicines available for use in many emergency departments to treat opioid use disorders (OUD). The materials were developed by emergency…

Quantum Units Education: New CEU Courses

Opioid Use Disorder: Partnering Clients, Health Care, and Addiction Professionals Opioid misuse has caused a growing nationwide epidemic of OUD and unintentional overdose deaths.  This CEU course provides information for professionals working with individual who take a Food and Drug Administration-approved medication for opioid use disorder. Chronic Pain and Opioid…

Quantum Units Education: New CEU Courses

Opioid Use Disorder: Medications, Screening, and Assessment The number of patients presenting with opioid use disorder (OUD) in medical clinics, community health centers, and private practices is increasing.  This CEU course offers a general introduction to providing medications to address OUD and addresses most personal healthcare needs, development of sustained…